Sagent Pharmaceuticals, a specialty pharmaceutical company focused on
developing, manufacturing, sourcing and marketing pharmaceutical products,
announced the voluntary nationwide recall of three lots of ketorolac
tromethamine injection, USP, 30mg/mL single-dose vials (NDC numbers 25021-701-01
and 25021-701-02) manufactured by Cadila Healthcare Limited and distributed by
Sagent.
Sagent has initiated this voluntary recall of ketorolac tromethamine injection, USP, 30mg/mL to the user level due to labelling the product with the incorrect expiration date. The labelled expiration date is longer than the known stability of the product.
Sagent is not aware of any adverse patient events resulting from the use of this product.
Sagent has initiated this voluntary recall of ketorolac tromethamine injection, USP, 30mg/mL to the user level due to labelling the product with the incorrect expiration date. The labelled expiration date is longer than the known stability of the product.
Sagent is not aware of any adverse patient events resulting from the use of this product.
No comments:
Post a Comment